Daniel Vitor Vasconcelos-Santos
Overview
Explore the profile of Daniel Vitor Vasconcelos-Santos including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
56
Citations
297
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Henriques P, Almeida G, Rimkute I, Dos Santos L, Liechti T, Marino A, et al.
Immunology
. 2025 Mar;
PMID: 40035468
Toxoplasma gondii is a highly versatile parasite that infects most warm-blooded animals and is a major cause of retinochoroiditis and uveitis in humans. The pathophysiology of these conditions remains poorly...
2.
Felin M, Wang K, Raggi C, Moreira A, Pandey A, Grose A, et al.
Curr Pediatr Rep
. 2023 Sep;
10(3):109-124.
PMID: 37744780
Purpose Of Review: Review comprehensive data on rates of toxoplasmosis in Panama and Colombia. Recent Findings: Samples and data sets from Panama and Colombia, that facilitated estimates regarding seroprevalence of...
3.
Cronemberger S, Vasconcelos-Santos D, Correia de Carvalho C, Carvalho Jr J, Calixto J, Diniz-Filho A
Eur J Ophthalmol
. 2023 May;
34(1):NP22-NP26.
PMID: 37160763
Introduction: Bilateral acute iris transillumination (BAIT) is a relatively new syndrome whose etiopathogenesis is still not fully understood. It is characterized by acute bilateral onset of intense pigment dispersion in...
4.
Felin M, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, et al.
Curr Pediatr Rep
. 2023 Mar;
10(3):93-108.
PMID: 36969368
Purpose Of Review: Review work to create and evaluate educational materials that could serve as a primary prevention strategy to help both providers and patients in Panama, Colombia, and the...
5.
Brandao-de-Resende C, Alcantara L, Vasconcelos-Santos D, Diniz-Filho A
J Glaucoma
. 2023 Feb;
32(5):327-332.
PMID: 36847715
Prcis: Teleglaucoma is the future, but there is a need for clearer regulation by government agencies and medical entities, as well as for studies to further demonstrate the cost-effectiveness and...
6.
Lage N, Paiva M, Vasconcelos-Santos D, Machado R, Fialho S, Silva-Cunha A
Pharmaceutics
. 2023 Jan;
15(1).
PMID: 36678822
Mometasone furoate (MF) is a medium-potency synthetic glucocorticosteroid with anti-inflammatory, antipruritic, and vasoconstrictive properties. However, its role in the treatment of ocular inflammation has not yet been explored. This work...
7.
Goh E, Putera I, La Distia Nora R, Mahendradas P, Biswas J, Chee S, et al.
Ocul Immunol Inflamm
. 2022 Sep;
31(7):1342-1361.
PMID: 36095008
Introduction: Ocular toxoplasmosis is the leading cause of posterior uveitis worldwide, affecting individuals acrossdifferent age groups. The key to reducing vision loss includes prompt diagnosis and treatment. However, despite the...
8.
Felin M, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, et al.
Curr Pediatr Rep
. 2022 Aug;
10(3):57-92.
PMID: 36034212
Purpose Of Review: Review building of programs to eliminate infections. Recent Findings: Morbidity and mortality from toxoplasmosis led to programs in USA, Panama, and Colombia to facilitate understanding, treatment, prevention,...
9.
Felin M, Wang K, Moreira A, Grose A, Leahy K, Zhou Y, et al.
Curr Pediatr Rep
. 2022 Aug;
10(3):125-154.
PMID: 35991908
Purpose Of Review: Review international efforts to build a global public health initiative focused on toxoplasmosis with spillover benefits to save lives, sight, cognition and motor function benefiting maternal and...
10.
Moreira Castro B, Nunes da Silva C, Cordeiro L, Cenachi S, Vasconcelos-Santos D, Machado R, et al.
Curr Res Pharmacol Drug Discov
. 2022 Jun;
3:100107.
PMID: 35647524
Uveitis is a group of sight-threatening ocular inflammatory disorders, whose mainstay of therapy is associated with severe adverse events, prompting the investigation of alternative treatments. The peptide melittin (MEL) is...